Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. Their findings were published on Friday, June 24, in The ...
Jun 26, 2021
0
21
A preclinical study has found multiple myeloma is highly sensitive to a newly developed experimental therapy, according to research published today by Peter Mac scientists.
May 21, 2021
0
39
An international team of researchers from Japan, the US and the UK has analyzed the function of the histone demethylase KDM5A in multiple myeloma, one of the three major hematological cancers, and clarified the mechanism ...
May 17, 2021
0
2
The resilience of cancer cells and their ability to survive in extreme conditions is a large part of what makes cancer so difficult to treat.
Apr 30, 2021
0
73
Abecma (idecabtagene vicleucel), a chimeric antigen receptor (CAR) T-cell therapy, was approved by the U.S. Food and Drug Administration for the treatment of multiple myeloma, the agency announced Saturday.
Mar 31, 2021
0
3
A new method makes it much easier to follow the progression of multiple myeloma, a form of blood cancer. With a single drop of blood, it is possible to very accurately show whether the number of cancerous cells in the bone ...
Mar 26, 2021
0
8
South Australian researchers are hoping to improve the outcome of patients with multiple myeloma after identifying a new protein associated with the most aggressive form of the disease.
Mar 09, 2021
0
4
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical trial has found.
Feb 25, 2021
0
22
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells' ...
Feb 12, 2021
0
83
Many patients with multiple myeloma, a type of blood cancer, eventually develop resistance to one treatment after another. That's in part because cancer stem cells drive the disease—cells that continually self-renew. If ...
Jan 20, 2021
0
129
